KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to 14.15%.

  • Chemed's EBITDA Margin fell 32200.0% to 14.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.02%, marking a year-over-year decrease of 15000.0%. This contributed to the annual value of 17.25% for FY2024, which is 400.0% down from last year.
  • According to the latest figures from Q3 2025, Chemed's EBITDA Margin is 14.15%, which was down 32200.0% from 13.21% recorded in Q2 2025.
  • In the past 5 years, Chemed's EBITDA Margin ranged from a high of 21.23% in Q4 2023 and a low of 13.21% during Q2 2025
  • For the 5-year period, Chemed's EBITDA Margin averaged around 17.3%, with its median value being 17.37% (2024).
  • Per our database at Business Quant, Chemed's EBITDA Margin plummeted by -7551100bps in 2021 and then soared by 41400bps in 2023.
  • Quarter analysis of 5 years shows Chemed's EBITDA Margin stood at 20.31% in 2021, then fell by -16bps to 17.09% in 2022, then increased by 24bps to 21.23% in 2023, then decreased by -6bps to 19.87% in 2024, then fell by -29bps to 14.15% in 2025.
  • Its EBITDA Margin was 14.15% in Q3 2025, compared to 13.21% in Q2 2025 and 16.73% in Q1 2025.